CICB Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline THG Q1 2026 Earnings Big EPS Beat Driven by Strong Underwriting Performance MGRB Q1 2026 Earnings Earnings Beat Estimates Amidst Modest Stock Decline